Global Attention Deficit and Hyperactivity Disorder Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Attention Deficit and Hyperactivity Disorder Market Insights, Forecast to 2034
Attention deficit hyperactivity disorder (ADHD) is a condition that affects people's behaviour. People with ADHD can seem restless, may have trouble concentrating and may act on impulse.
Market Analysis and InsightsGlobal Attention Deficit and Hyperactivity Disorder Market
Global Attention Deficit and Hyperactivity Disorder market is expected to reach to US$ 20500 million in 2024, with a positive growth of %, compared with US$ 19160 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Attention Deficit and Hyperactivity Disorder industry is evaluated to reach US$ 30770 million in 2029. The CAGR will be 7.0% during 2024 to 2029.
The Attention Deficit and Hyperactivity Disorder (ADHD) market is driven by the rising awareness of the disorder and its diagnosis, coupled with the increasing prevalence of ADHD among children and adults. ADHD is a neurodevelopmental disorder characterized by symptoms of inattention, hyperactivity, and impulsivity. The growing recognition of the impact of ADHD on daily life, educational performance, and workplace productivity contributes to market growth as individuals and healthcare providers seek effective treatment options. Moreover, advancements in diagnostic methods, therapy approaches, and medication options align with improved management of ADHD symptoms. However, the market also faces challenges, including accurate diagnosis and tailoring treatment plans to individual patient needs. Additionally, addressing concerns about overdiagnosis and appropriate medication usage can pose obstacles for healthcare professionals. To succeed, stakeholders must focus on providing comprehensive assessment and tailored interventions, fostering public awareness, and addressing the challenges to meet the increasing demand for accurate diagnosis and effective management of ADHD.
Report Covers
This report presents an overview of global Attention Deficit and Hyperactivity Disorder market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Attention Deficit and Hyperactivity Disorder market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Takeda
Johnson & Johnson
Novartis
Eli Lilly
Tris Pharma
Neos Therapeutics
Mallinckrodt
Amneal Pharmaceuticals
Noven Pharmaceuticals
Purdue Parma
Segment by Type
Stimulant
Non-stimulant
Hospital
Retail Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Attention Deficit and Hyperactivity Disorder introduction, etc. Attention Deficit and Hyperactivity Disorder Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Attention Deficit and Hyperactivity Disorder
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports
Market Analysis and InsightsGlobal Attention Deficit and Hyperactivity Disorder Market
Global Attention Deficit and Hyperactivity Disorder market is expected to reach to US$ 20500 million in 2024, with a positive growth of %, compared with US$ 19160 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Attention Deficit and Hyperactivity Disorder industry is evaluated to reach US$ 30770 million in 2029. The CAGR will be 7.0% during 2024 to 2029.
The Attention Deficit and Hyperactivity Disorder (ADHD) market is driven by the rising awareness of the disorder and its diagnosis, coupled with the increasing prevalence of ADHD among children and adults. ADHD is a neurodevelopmental disorder characterized by symptoms of inattention, hyperactivity, and impulsivity. The growing recognition of the impact of ADHD on daily life, educational performance, and workplace productivity contributes to market growth as individuals and healthcare providers seek effective treatment options. Moreover, advancements in diagnostic methods, therapy approaches, and medication options align with improved management of ADHD symptoms. However, the market also faces challenges, including accurate diagnosis and tailoring treatment plans to individual patient needs. Additionally, addressing concerns about overdiagnosis and appropriate medication usage can pose obstacles for healthcare professionals. To succeed, stakeholders must focus on providing comprehensive assessment and tailored interventions, fostering public awareness, and addressing the challenges to meet the increasing demand for accurate diagnosis and effective management of ADHD.
Report Covers
This report presents an overview of global Attention Deficit and Hyperactivity Disorder market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Attention Deficit and Hyperactivity Disorder market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Takeda
Johnson & Johnson
Novartis
Eli Lilly
Tris Pharma
Neos Therapeutics
Mallinckrodt
Amneal Pharmaceuticals
Noven Pharmaceuticals
Purdue Parma
Segment by Type
Stimulant
Non-stimulant
Segment by Application
Hospital
Retail Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Attention Deficit and Hyperactivity Disorder introduction, etc. Attention Deficit and Hyperactivity Disorder Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Attention Deficit and Hyperactivity Disorder
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports